Media coverage
11
Media coverage
Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet TMC Net Country/Territory United States Date 21/02/18 URL www.tmcnet.com/usubmit/-eyenovia-advances-micropine-myopia-into-phase-iii-clinical-/2018/02/21/8704202.htm Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet PharmiWeb Country/Territory United Kingdom Date 21/02/18 URL https://www.pharmiweb.com/pressreleases/pressrel.asp?row_id=265551 Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet SPi World News Country/Territory United Kingdom Date 21/02/18 URL www.sectorpublishingintelligence.co.uk/news/1908263/eyenovia+advances+micropine+for+myopia+into+phase+iii+clinical+development+and+appoints+stanford+professor+dr+douglas+fredrick+to+its+scientific+advisory+board+and+myopia+program+steering+committee Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet Nasdaq Country/Territory United States Date 21/02/18 URL https://www.nasdaq.com/press-release/eyenovia-advances-micropine-for-myopia-into-phase-iii-clinical-development-and-appoints-stanford-20180221-00612 Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet Pettinga Financial Advisors Country/Territory United States Date 21/02/18 URL markets.pettinga.com/pettinga/news/read?GUID=35819117 Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet 4 Traders Country/Territory United States Date 21/02/18 URL www.4-traders.com/EYENOVIA-INC-40331595/news/Eyenovia-Advances-MicroPine-for-Myopia-into-Phase-III-Clinical-Development-and-Appoints-Stanford-Pro-26029169/ Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet Pharmacy Choice Country/Territory United States Date 21/02/18 URL www.pharmacychoice.com/news/article.cfm?Article_ID=1949932 Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 21/02/18 Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet Daily Times Leader Country/Territory United States Date 21/02/18 URL business.dailytimesleader.com/dailytimesleader/news/read?GUID=35819117 Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet 35 WSEE Country/Territory United States Date 21/02/18 URL www.erienewsnow.com/story/37555596/eyenovia-advances-micropine-for-myopia-into-phase-iii-clinical-development-and-appoints-stanford-professor-dr-douglas-fredrick-to-its-scientific Persons Douglas Fredrick Title Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee Media name/outlet BizWire Express Country/Territory India Date 21/02/18 URL www.bizwireexpress.com/showstoryGNW.php?storyid=226554 Persons Douglas Fredrick